Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review ; day:16 ; month:10 ; year:2022 ; pages:1-26
Advances in therapy ; (16.10.2022), 1-26
- Creator
-
Ballestri, Stefano
Romagnoli, Elisa
Arioli, Dimitriy
Coluccio, Valeria
Marrazzo, Alessandra
Athanasiou, Afroditi
Di Girolamo, Maria
Cappi, Cinzia
Marietta, Marco
Capitelli, Mariano
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02333-9
- URN
-
urn:nbn:de:101:1-2023010109075558414494
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ballestri, Stefano
- Romagnoli, Elisa
- Arioli, Dimitriy
- Coluccio, Valeria
- Marrazzo, Alessandra
- Athanasiou, Afroditi
- Di Girolamo, Maria
- Cappi, Cinzia
- Marietta, Marco
- Capitelli, Mariano
- SpringerLink (Online service)
Other Objects (12)
Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
Management of bleeding in patients treated with direct oral anticoagulants
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
Management of bleeding in patients treated with direct oral anticoagulants
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
Management of bleeding in patients treated with direct oral anticoagulants
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin